Delivery Order SPE2DB25D3020-SPE2DB25FWHVF
Award Date
6/3/25
Potential Completion Date
6/25/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order worth $13,246.00 for the supply of Esbriet 267 mg tablets. The contract, which has an ultimate completion date of October 16, 2024, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency responsible for providing medical supplies to the U.S. military. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,851.90 firm fixed-price delivery order is for the supply of 4,568,160,448 tablets of the medication Esbriet 267 mg. The contract has a performance period through May 28, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $3,425.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the prescription medication Esbriet 267 mg tablets, with a performance period extending through May 7, 2025. The contract is a Firm Fixed Price Delivery Order and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant...
This contract award, valued at $3,425.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Esbriet 801 mg tablets, a pharmaceutical product, with a completion date of February 5, 2025. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $3,425.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Esbriet 801 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a $3,311.50 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the delivery of Esbriet 801 mg tablets and has a period of performance through July 29, 2024. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to supply Esbriet 801 mg tablets to the government. The Delivery Order, valued at $3,311.50, has a firm fixed price and an ultimate completion date of July 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 firm fixed-price delivery order is for 270 tablets of the drug Esbriet (pirfenidone) 267 mg. The contract has a completion date of June 27, 2025. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not designated as a set-aside. The company also holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Esbriet 801 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price of $3,311.50 and a ceiling value of $3,311.50. The contract has an ultimate completion date of May 20, 2024. Amerisourcebergen Drug Corp is the prime contractor, and its parent company is Cencora, Inc. (doing business as Amerisourcebergen). This...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of Esbriet 801 mg tablets in quantities of 90 per bottle. The contract, valued at $3,311.50, was awarded by the Defense Logistics Agency (DLA) and does not have a set-aside designation. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of...